An 8-Year Experience of Direct-to-Implant Immediate Breast Reconstruction Using Human Acellular Dermal Matrix (AlloDerm)
Top Cited Papers
- 1 February 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Plastic and Reconstructive Surgery
- Vol. 127 (2), 514-524
- https://doi.org/10.1097/prs.0b013e318200a961
Abstract
The advent of skin- and nipple-sparing mastectomy in conjunction with the use of human acellular dermal matrix to provide lower pole coverage has made direct-to-implant immediate breast reconstruction following mastectomy feasible. The purpose of this study was to evaluate long-term complications associated with this technique. All human acellular dermal matrix-assisted direct-to-implant immediate reconstructions performed over an 8-year period were included in this analysis. Patient charts were reviewed for type of mastectomy (oncologic or prophylactic), incision type, complications during follow-up, length of follow-up, rate and type of revision surgery in breasts without postoperative complications, contralateral procedures, and adjuvant radiotherapy. A total of 466 breasts (260 patients) were reconstructed; 68 percent were prophylactic and 32 percent were oncologic cases. Twenty-one breasts (4.5 percent) received radiotherapy. Mean implant size placed was 412.8 ± 24.7 cc (range, 150 to 600 cc). Mean follow-up was 28.9 ± 21.3 months (range, 0.3 to 97.7 months). The overall complication rate was 3.9 percent (implant loss, 1.3 percent; skin breakdown/necrosis, 1.1 percent; hematoma, 1.1 percent; human acellular dermal matrix exposure, 0.6 percent; capsular contracture, 0.4 percent; and infection, 0.2 percent). Type, incidence, and overall rate of complications did not differ significantly between prophylactic and oncologic breasts. Irradiated breasts had a fourfold higher rate of complications. In 354 breasts with more than 1 year of follow-up (mean, 36.7 ± 18.6 months; range, 12.1 to 97.7 months), there were no long-term complications. Human acellular dermal matrix-assisted direct-to-implant breast reconstruction following mastectomy is safe and reliable, with a low overall long-term complication rate. The low incidence of capsular contracture supports the growing body of evidence that human acellular dermal matrix mitigates capsular contracture.Keywords
This publication has 32 references indexed in Scilit:
- The Effect of Acellular Dermal Matrix Use on Complication Rates in Tissue Expander/Implant Breast ReconstructionAnnals of Plastic Surgery, 2010
- Implant-Based Breast Reconstruction Using Acellular Dermal Matrix and the Risk of Postoperative ComplicationsPlastic and Reconstructive Surgery, 2010
- Expander/Implant Reconstruction with AlloDerm: Recent ExperiencePlastic and Reconstructive Surgery, 2009
- Radiation Therapy and Breast Reconstruction: A Critical Review of the LiteraturePlastic and Reconstructive Surgery, 2009
- Immediate Single-Stage Breast Reconstruction Using Implants and Human Acellular Dermal Tissue Matrix With Adjustment of the Lower Pole of the Breast to Reduce Unwanted LiftAnnals of Plastic Surgery, 2008
- The Influence of AlloDerm on Expander Dynamics and Complications in the Setting of Immediate Tissue Expander/Implant ReconstructionAnnals of Plastic Surgery, 2008
- Long-term outcome after mastectomy with immediate breast reconstructionActa Oncologica, 2008
- Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis:the adverse effect of radiotherapyEuropean Journal of Surgical Oncology, 2000
- Allograft Dermal Implant (AlloDerm) in a Previously Irradiated FieldThe Laryngoscope, 2000
- The “Living Bra” in Immediate and Delayed Reconstruction of the Breast Following Mastectomy for Malignant and Nonmalignant DiseasePlastic and Reconstructive Surgery, 1981